Persistence Market Research Company
Customize Now Get FREE Sample

Cancer Molecular Biomarkers Market Size, Share and Growth Forecast, 2026-2033

Cancer Molecular Biomarkers Market by Biomarker Type (Genetic, Transcriptomic, Proteomic, Epigenetic, Metabolic, Cell-based, Exosome-derived), Profiling Technology (Next-Generation Sequencing (NGS), Omics, Spectrometry, Bioinformatics Analytics, Others), Cancer Type (Breast Cancer, Lung Cancer, Cervical Cancer, Ovarian Cancer, Others), End-Use (Clinical Diagnostics, Therapeutic Monitoring, Clinical Research, Biopharmaceutical Companies, Others), and Regional Analysis for 2026-2033

ID: PMRREP3841| 298 Pages | 10 Feb 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Cancer Molecular Biomarkers Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 – 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Tool Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Price Analysis, 2026A
    1. Key Highlights
    2. Key Factors Impacting Deployment Costs
    3. Pricing Analysis, By Biomarker Type
  5. Global Cancer Molecular Biomarkers Market Outlook
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2.  Market Size (US$ Bn) Analysis and Forecast, 2026 – 2033
    3. Global Cancer Molecular Biomarkers Market Outlook: Biomarker Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Biomarker Type, 2020 – 2025
      3.  Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 – 2033
        1. Genetic
        2. Transcriptomic
        3. Proteomic
        4. Epigenetic
        5. Metabolic
        6. Cell based
        7. Exosome derived
      4. Market Attractiveness Analysis: Biomarker Type
    4. Global Cancer Molecular Biomarkers Market Outlook: Profiling Technology
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Profiling Technology, 2020 – 2025
      3.  Market Size (US$ Bn) Analysis and Forecast, By Profiling Technology, 2026 – 2033
        1. Next-Generation Sequencing (NGS)
        2. Omics Technologies
        3. Spectrometry
        4. Bioinformatics Analytics
        5. Others
      4. Market Attractiveness Analysis: Profiling Technology
    5. Global Cancer Molecular Biomarkers Market Outlook: Cancer Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Cancer Type, 2020 – 2025
      3.  Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2026 – 2033
        1. Breast Cancer
        2. Lung Cancer
        3. Cervical Cancer
        4. Ovarian Cancer
        5. Others
      4. Market Attractiveness Analysis: Cancer Type
    6. Global Cancer Molecular Biomarkers Market Outlook: End-Use
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End-Use, 2020 – 2025
      3.  Market Size (US$ Bn) Analysis and Forecast, By End-Use, 2026 – 2033
        1. Clinical Diagnostics
        2. Therapeutic Monitoring
        3. Clinical Research
        4. Biopharmaceutical Companies
        5. Others

Market Attractiveness Analysis: End-Use

  1. Global Cancer Molecular Biomarkers Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2020 – 2025
    3.  Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2026 – 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  2. North America Cancer Molecular Biomarkers Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Biomarker Type
      3. By Profiling Technology
      4. By Cancer Type
    3.  Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. U.S.
      2. Canada
    4.  Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 – 2033
      1. Genetic
      2. Transcriptomic
      3. Proteomic
      4. Epigenetic
      5. Metabolic
      6. Cell based
      7. Exosome derived
    5.  Market Size (US$ Bn) Analysis and Forecast, By Profiling Technology, 2026 – 2033
      1. Next-Generation Sequencing (NGS)
      2. Omics Technologies
      3. Spectrometry
      4. Bioinformatics Analytics
      5. Others
    6.  Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2026-2033
      1. Breast Cancer
      2. Lung Cancer
      3. Cervical Cancer
      4. Ovarian Cancer
      5. Others
    7.  Market Size (US$ Bn) Analysis and Forecast, By End-Use, 2026-2033
      1. Clinical Diagnostics
      2. Therapeutic Monitoring
      3. Clinical Research
      4. Biopharmaceutical Companies
      5. Others
    8. Market Attractiveness Analysis
  3. Europe Cancer Molecular Biomarkers Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Biomarker Type
      3. By Profiling Technology
      4. Cancer Type
    3.  Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4.  Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 – 2033
      1. Genetic
      2. Transcriptomic
      3. Proteomic
      4. Epigenetic
      5. Metabolic
      6. Cell based
      7. Exosome derived
    5.  Market Size (US$ Bn) Analysis and Forecast, By Profiling Technology, 2026 – 2033
      1. Next-Generation Sequencing (NGS)
      2. Omics Technologies
      3. Spectrometry
      4. Bioinformatics Analytics
      5. Others
    6.  Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2026-2033
      1. Breast Cancer
      2. Lung Cancer
      3. Cervical Cancer
      4. Ovarian Cancer
      5. Others
    7.  Market Size (US$ Bn) Analysis and Forecast, By End-Use, 2026-2033
      1. Clinical Diagnostics
      2. Therapeutic Monitoring
      3. Clinical Research
      4. Biopharmaceutical Companies
      5. Others
    1. Market Attractiveness Analysis
  2. East Asia Cancer Molecular Biomarkers Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Biomarker Type
      3. By Profiling Technology
      4. By Cancer Type
    3.  Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. China
      2. Japan
      3. South Korea
    4.  Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 – 2033
      1. Genetic
      2. Transcriptomic
      3. Proteomic
      4. Epigenetic
      5. Metabolic
      6. Cell based
      7. Exosome derived
    5.  Market Size (US$ Bn) Analysis and Forecast, By Profiling Technology, 2026 – 2033
      1. Next-Generation Sequencing (NGS)
      2. Omics Technologies
      3. Spectrometry
      4. Bioinformatics Analytics
      5. Others
    6.  Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2026-2033
      1. Breast Cancer
      2. Lung Cancer
      3. Cervical Cancer
      4. Ovarian Cancer
      5. Others
    1.  Market Size (US$ Bn) Analysis and Forecast, By End-Use, 2026-2033
      1. Clinical Diagnostics
      2. Therapeutic Monitoring
      3. Clinical Research
      4. Biopharmaceutical Companies
      5. Others
    1. Market Attractiveness Analysis
  2. South Asia & Oceania Cancer Molecular Biomarkers Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Biomarker Type
      3. By Profiling Technology
      4. By Cancer Type
    3.  Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4.  Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 – 2033
      1. Genetic
      2. Transcriptomic
      3. Proteomic
      4. Epigenetic
      5. Metabolic
      6. Cell based
      7. Exosome derived
    5.  Market Size (US$ Bn) Analysis and Forecast, By Profiling Technology, 2026 – 2033
      1. Next-Generation Sequencing (NGS)
      2. Omics Technologies
      3. Spectrometry
      4. Bioinformatics Analytics
      5. Others
    6.  Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2026-2033
      1. Breast Cancer
      2. Lung Cancer
      3. Cervical Cancer
      4. Ovarian Cancer
      5. Others
    1.  Market Size (US$ Bn) Analysis and Forecast, By End-Use, 2026-2033
      1. Clinical Diagnostics
      2. Therapeutic Monitoring
      3. Clinical Research
      4. Biopharmaceutical Companies
      5. Others
    1. Market Attractiveness Analysis
  2. Latin America Cancer Molecular Biomarkers Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Biomarker Type
      3. By Profiling Technology
      4. By Cancer Type
    3.  Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4.  Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 – 2033
      1. Genetic
      2. Transcriptomic
      3. Proteomic
      4. Epigenetic
      5. Metabolic
      6. Cell based
      7. Exosome derived
    5.  Market Size (US$ Bn) Analysis and Forecast, By Profiling Technology, 2026 – 2033
      1. Next-Generation Sequencing (NGS)
      2. Omics Technologies
      3. Spectrometry
      4. Bioinformatics Analytics
      5. Others
    6.  Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2026-2033
      1. Breast Cancer
      2. Lung Cancer
      3. Cervical Cancer
      4. Ovarian Cancer
      5. Others
    1. Market Size (US$ Bn) Analysis and Forecast, By End-Use, 2026-2033
      1. Clinical Diagnostics
      2. Therapeutic Monitoring
      3. Clinical Research
      4. Biopharmaceutical Companies
      5. Others

 

    1. Market Attractiveness Analysis
  2. Middle East & Africa Cancer Molecular Biomarkers Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Biomarker Type
      3. By Profiling Technology
      4. By Cancer Type
    3.  Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 – 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4.  Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 – 2033
      1. Genetic
      2. Transcriptomic
      3. Proteomic
      4. Epigenetic
      5. Metabolic
      6. Cell based
      7. Exosome derived
    5.  Market Size (US$ Bn) Analysis and Forecast, By Profiling Technology, 2026 – 2033
      1. Next-Generation Sequencing (NGS)
      2. Omics Technologies
      3. Spectrometry
      4. Bioinformatics Analytics
      5. Others
    6.  Market Size (US$ Bn) Analysis and Forecast, By Cancer Type, 2026-2033
      1. Breast Cancer
      2. Lung Cancer
      3. Cervical Cancer
      4. Ovarian Cancer
      5. Others
    1. Market Size (US$ Bn) Analysis and Forecast, By End-Use, 2026-2033
      1. Clinical Diagnostics
      2. Therapeutic Monitoring
      3. Clinical Research
      4. Biopharmaceutical Companies
      5. Others
    1. Market Attractiveness Analysis
  2. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
      1. Illumina, Inc.
        1. Overview
        2. Segments and Deployments
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Thermo Fisher Scientific
      3. Roche Diagnostics
      4. Qiagen NV
      5. F. Hoffmann La Roche AG
      6. Abbott Laboratories
      7. Bio Rad Laboratories
      8. Agilent Technologies
      9. Becton, Dickinson and Company
      10. Guardant Health
      11. Foundation Medicine
      12. Exact Sciences Corporation
      13. Novartis AG
  3. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate